<DOC>
	<DOCNO>NCT01155986</DOCNO>
	<brief_summary>The purpose trial investigate efficacy safety lidocaine 5 % medicate plaster localize chronic post-operative neuropathic pain comparison placebo plaster .</brief_summary>
	<brief_title>Lidocaine 5 % Medicated Plaster Chronic Neuropathic Postoperative Pain</brief_title>
	<detailed_description>Some patient undergo different type surgery develop distress long-lasting pain . This pain often characterized sign : allodynia ( pain due stimulus normally provoke pain ) , dysesthesia ( unpleasant , abnormal sense touch ) . Patients describe symptom burn electrical type sensation . In case type chronic pain still present 3 month follow surgery.This clinical trial ass efficacy safety profile lidocaine 5 % medicate plaster comparison placebo plaster patient . This trial randomize , double-blind ( neither investigator patient know treatment receive ) , placebo-controlled , parallel-group , multicenter trial evaluate topical analgesic treatment chronic neuropathic pain surgery . The trial include screen phase treatment phase , subject treat either 5 % lidocaine medicate plaster , placebo plaster pain intensity assess daily basis . Subsequently follow-up phase . Pain intensity numeric rating scale ( PI ) collect via numeric rating scale average . Safety evaluation include monitor adverse event , physical examination , clinical laboratory test .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Male female subject &gt; = 18 year age Intact skin area topical treatment Patients suffer moderate severe ( 5 point 11 point Numerical Rating Scale 10 bad possible pain , 0 indicates pain ) chronic daily postoperative neuropathic pain past 6 24 month . Patients symptoms example allodynia ( pain due stimulus normally provoke pain ) ; dysesthesia ( unpleasant , abnormal sense touch ) . Contraindications lidocaine 5 % medicate plaster , paracetamol Evidence history alcohol , medication drug abuse and/or dependency past 3 year . Evidence history ( past 3 year ) epilepsy , neurotic personality , psychiatric illness , suicide risk . Pregnant breastfeed woman Women childbearing potential sexually active without satisfactory contraception least 28 day prior enrollment , trial , 28 day followup visit . Severe renal , hepatic heart disorder . Surgery past 3 month screen . Anticipated need surgery trial , require least regional general anesthesia . Pending litigation due chronic pain disability . Participation another trial investigational medicinal product device parallel less 1 month entry trial , previous participation trial . Presence severe pain could confound assessment self evaluation localize postoperative neuropathic pain . For patient chronic postoperative neuropathic pain related surgery due tumor : suspect residual tumor metastasis , chemotherapy radiotherapy treatment tumor ( ) . Total anesthesia area localize chronic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>analgesic</keyword>
	<keyword>analgesic</keyword>
	<keyword>pain</keyword>
	<keyword>chronic pain</keyword>
	<keyword>localize pain</keyword>
	<keyword>focal pain</keyword>
	<keyword>neuropathic pain</keyword>
	<keyword>postoperative pain</keyword>
	<keyword>topical analgesia</keyword>
</DOC>